Vascular bypass grafts often fail when neointimal fibromuscular hyperplasia (NFH) causes stenosis and flow reduction. The usual explanation of NFH is that platelets adhere to grafts and release a platelet-derived growth factor (PDGF) which is mitogenic and chemotactic for vascular smooth muscle cells (SMC). But this """"""""platelet-based"""""""" theory is weakened by evidence that NFH can occur (a) despite antiplatelet drug use and (b) in areas covered by endothelium which prevents platelets adhesion. The discovery that endothelial cells (EC) can make SMC mitogens suggests a different hypotheses: That EC are (i) normally in a nonproliferating state on normal basement membranes with little or no SMC mitogen release, but (ii) undergo a phenotype change to high SMC mitogen synthesis and release when stimulated to proliferate on fibrin thrombi or fibronectin coated grafts during a wound healing response, and (iii) that the SMC mitogens made by damaged or proliferating EC on grafts or host vessels act on subjacent SMC to cause NFH. We will do four kinds of experiments to test this hypothesis: (1) We will study how SMC mitogen gene expression and release from EC are regulated by (a) extracellular matrix components (fibronectin, laminin, and basement-membrane-like complexes) and (b) by growth factors and heparin used to grow adult human EC for graft linings. These effects will be measured by dot blots for PDGF gene transcription, mitogen release assays of conditioned medium, and flow cytometry of DNA levels. (2) To see if increased SMC mitogen gene transcription occurs in vivo at sites of NFH, we will use in situ hybridization of radioactive labeled cDNA probes for SMC mitogen mRNA sequences to study NFH lesions from stenosed coronary bypass grafts. This will allow histologic detection of SMC mitogen gene expression in EC or SMC at NFH sites. (3) To see if EC-derived SMC mitogens can act directly on subjacent SMC layers, we will cocultivate EC and SMC layers in direct contact in dishes and tubular graft models and use flow cytometry to measure the mitogenic response of the SMC to controlled changes in endothelial production of SMC mitogens. (4) If we find that SMC mitogens can cause SMC hyperplasia in such models and are transcribed in vivo in NFH lesions, we will try to construct graft surfaces which mimic normal basement membrane and which can make EC revert to a quiescent phenotype where SMC mitogen production is reduced or absent and EC-platelet or EC-white cell interaction would be minimized on EC-seeded grafts with such linings.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL040680-02
Application #
3357951
Study Section
Surgery and Bioengineering Study Section (SB)
Project Start
1988-07-01
Project End
1991-06-30
Budget Start
1989-07-01
Budget End
1990-06-30
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Henry M. Jackson Fdn for the Adv Mil/Med
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20852
Yamaguchi, M; Gallati, H; Baur, W et al. (1994) Both lisinopril and verapamil reduced platelet-derived growth factor-A chain mRNA levels in human saphenous vein endothelial cells stimulated by thrombin. Surgery 115:495-502
Yamaguchi, M; Diamond, S; Watanabe, H et al. (1993) Heparin and dibutyryl cAMP modulate gene expression in stimulated human saphenous vein smooth muscle cells. In Vitro Cell Dev Biol Anim 29A:867-72
Raftery, K; Sharefkin, J; Limanni, A et al. (1993) Construction of overlapping oligonucleotide templates for the production of cRNA standards for quantitative reverse transcription polymerase chain reaction. Diagn Mol Pathol 2:120-4
Yamaguchi, M; Dieffenbach, C W; Connolly, R et al. (1992) Effect of different laboratory techniques for guanidinium-phenol-chloroform RNA extraction on A260/A280 and on accuracy of mRNA quantitation by reverse transcriptase-PCR. PCR Methods Appl 1:286-90
Yamaguchi, M; Du, W; Gould, K E et al. (1991) Effects of aspirin, dipyridamole, and dibutyryl cyclic adenosine monophosphate on platelet-derived growth factor A chain mRNA levels in human saphenous vein endothelial cells and smooth muscle cells. Surgery 110:377-83;discussion 383-4
Sharefkin, J B; Diamond, S L; Eskin, S G et al. (1991) Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J Vasc Surg 14:1-9
Diamond, S L; Sharefkin, J B; Dieffenbach, C et al. (1990) Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress. J Cell Physiol 143:364-71
Lowe, T; Sharefkin, J; Yang, S Q et al. (1990) A computer program for selection of oligonucleotide primers for polymerase chain reactions. Nucleic Acids Res 18:1757-61
Wang, Z G; Du, W; Li, G D et al. (1990) Rapid cellular luminal coverage of Dacron inferior vena cava prostheses in dogs by immediate seeding of autogenous endothelial cells derived from omental tissue: results of a preliminary trial. J Vasc Surg 12:168-79